Practice guidelines developed by specialty societies: the need for a critical appraisal

被引:491
作者
Grilli, R
Magrini, N
Penna, A
Mura, G
Liberati, A
机构
[1] Ist Ric Farmacol Mario Negri, Milan, Italy
[2] Ctr Valutaz Efficacia Assistenza Sanit, Modena, Italy
关键词
D O I
10.1016/S0140-6736(99)02171-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There is increasing concern about the quality, reliability, and independence of practice guidelines. Because no information is available on the methodological quality of the guidelines developed by specialty societies, we undertook a survey on those published in peer-reviewed journals. Methods Practice guidelines produced by specialty societies and published in English between January, 1988, and July, 1998, where identified through MEDLINE, Their quality was assessed in terms of whether they reported: the type of professionals and stakeholders involved in the development process; the strategy to identify primary evidence; and an explicit grading of recommendations according to the quality of supporting evidence. Findings Overall, 431 guidelines were eligible for the study. Most did not meet the criteria: 67% did not report any description of the type of stakeholders, 88% gave no information on searches for published studies, and 82% did not give any explicit grading of the strength of recommendations. There was improvement over time for searches (from 2% to 18%, p<0.001) and explicit grading of evidence (from 6% to 27%, p<0.001). All three criteria for quality were met in only 22 (5%) guidelines. Interpretation Despite improvement over time, the quality of practice guidelines developed by specialty societies is unsatisfactory. Explicit methodological criteria for the production of guidelines shared among public agencies, scientific societies, and patients' associations need to be set up. Common standards of reporting, following the same principles that led to the CONSORT statement for randomised clinical trials, should be promoted.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 20 条
[11]   A QUALITY ASSESSMENT OF RANDOMIZED CONTROL TRIALS OF PRIMARY-TREATMENT OF BREAST-CANCER [J].
LIBERATI, A ;
HIMEL, HN ;
CHALMERS, TC .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (06) :942-951
[12]  
LITTLEJOHNS P, 1997, PROMOTING RIGOROUS D
[13]  
MOHER D, 1996, LANCET, V347, P263
[14]   Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature [J].
Shaneyfelt, TM ;
Mayo-Smith, MF ;
Rothwangl, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (20) :1900-1905
[15]   MODERN METHODS OF SEARCHING THE MEDICAL LITERATURE .14. [J].
SMITH, BJ ;
DARZINS, PJ ;
QUINN, M ;
HELLER, RF .
MEDICAL JOURNAL OF AUSTRALIA, 1992, 157 (09) :603-611
[16]   Conflict of interest in the debate over calcium-channel antagonists [J].
Stelfox, HT ;
Chua, G ;
O'Rourke, K ;
Detsky, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :101-106
[17]   Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment [J].
Thomson, R ;
McElroy, H ;
Sudlow, M .
BRITISH MEDICAL JOURNAL, 1998, 316 (7130) :509-513
[18]  
Unwin N, 1998, BMJ-BRIT MED J, V317, P1125
[19]   Practice guidelines in Finland: Availability and quality [J].
Varonen, H ;
Makela, M .
QUALITY IN HEALTH CARE, 1997, 6 (02) :75-79
[20]   Open letter disputes WHO hypertension guidelines [J].
Woodman, R .
BRITISH MEDICAL JOURNAL, 1999, 318 (7188) :893-893